ArticleBMC microbiology2025
High prevalence of MDR and XDR Escherichia coli in hospital wastewater from Shiraz, Iran: ESBL and carbapenemase production.
Article in BMC microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHospital wastewater (HWW) is a significant reservoir for multidrug-resistant (MDR) bacteria and antimicrobial resistance (AMR) genes, posing serious public health risks. This study investigated the phenotypic and genotypic resistance profiles of Escherichia coli (E. coli) isolates from HWW in Shiraz, Iran. Thirty-six HWW samples (18 influent, 18 effluent) were collected weekly over six weeks from three major hospitals. E. coli isolates were identified and assessed for antimicrobial susceptibility, extended-spectrum β-lactamase (ESBL) and carbapenemase production, resistance genes, phylogroups, and sequence types (STs).
resultsA total of 68 E. coli isolates were obtained (33 influent, 35 effluent). High resistance rates were observed for ampicillin (97.1%), cefazolin, and amoxicillin/clavulanic acid (86.8%). The lowest resistance rates were to imipenem (5.9%), meropenem (13.2%), and chloramphenicol (19.1%). MDR and extensively drug-resistant (XDR) profiles were identified in 80.9% and 22.1% of isolates, respectively. ESBL production was found in 57.4% of isolates. All nine carbapenem-resistant isolates were tested by both modified carbapenem inactivation method (mCIM) and EDTA-CIM (eCIM); eight (88.9%) were positive by mCIM, while all were negative by eCIM. Resistance genes detected included blaTEM (39.7%), blaCTX-M (33.8%), and blaSHV (2.9%). Three isolates carried blaOXA-48, while one carried blaIMP and another carried blaVIM. Phylogroup B2 was most frequent (22.1%), with ST131 being the dominant type (33.8%).
conclusionIn conclusion, HWW may serve as a potential reservoir for resistant and pathogenic E. coli isolates, indicating the importance of monitoring wastewater as a step in addressing the issue of AMR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.